New research indicates that patients with metastatic ERBB2-positive disease and triple-negative breast cancer face the greatest risk. This data may help inform screening for brain metastases.
A major bill expanding health care and benefits for veterans exposed to toxic military burn pits in Iraq and Afghanistan passed the US Senate on Thursday, as senators praised their bipartisan work on one of the few issues they can find common ground.
Combining dabrafenib with trametinib markedly improved response rates and delayed progression over standard-of-care chemotherapy in pediatric BRAF V600-mutant low-grade glioma in a phase 2 trial.